GN0M.DE vs. DXSE.DE
GN0M.DE (Global X Genomics & Biotechnology UCITS ETF) and DXSE.DE (Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C) are both Health & Biotech Equities funds - GN0M.DE tracks the Solactive Genomics while DXSE.DE tracks the MSCI Europe Health Care ESG Screened 20-35. Both are passively managed. Over the past 3 years, GN0M.DE returned -1.90%/yr vs 2.51%/yr for DXSE.DE. At a 0.38 correlation, their price movements are largely independent. GN0M.DE charges 0.50%/yr vs 0.17%/yr for DXSE.DE.
Performance
GN0M.DE vs. DXSE.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GN0M.DE achieves a 12.99% return, which is significantly higher than DXSE.DE's -1.95% return.
GN0M.DE
- 1D
- 5.61%
- 1M
- 11.50%
- YTD
- 12.99%
- 6M
- 9.82%
- 1Y
- 55.73%
- 3Y*
- -1.90%
- 5Y*
- —
- 10Y*
- —
DXSE.DE
- 1D
- 2.90%
- 1M
- 0.52%
- YTD
- -1.95%
- 6M
- -0.32%
- 1Y
- 5.13%
- 3Y*
- 2.51%
- 5Y*
- 5.38%
- 10Y*
- 6.10%
GN0M.DE vs. DXSE.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GN0M.DE Global X Genomics & Biotechnology UCITS ETF | 12.99% | 5.67% | -12.40% | -9.04% | -32.50% | -7.90% |
DXSE.DE Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C | -1.95% | 4.97% | 4.52% | 9.56% | -5.75% | 1.86% |
Correlation
The correlation between GN0M.DE and DXSE.DE is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.50 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.36 |
Correlation (All Time) Calculated using the full available price history since Nov 12, 2021 | 0.38 |
The correlation between GN0M.DE and DXSE.DE shifts across timeframes, from 0.36 (3 years) to 0.50 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GN0M.DE vs. DXSE.DE — Risk / Return Rank
GN0M.DE
DXSE.DE
GN0M.DE vs. DXSE.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GN0M.DE | DXSE.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.73 | ||
| Sortino ratioReturn per unit of downside risk | +2.29 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.06 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 3.32 | 0.38 | +2.95 |
| Martin ratioReturn relative to average drawdown | 8.35 | 0.82 | +7.53 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GN0M.DE | DXSE.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.00 | 0.27 | +1.73 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.32 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.38 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.34 | 0.45 | -0.79 |
Drawdowns
GN0M.DE vs. DXSE.DE - Drawdown Comparison
The maximum GN0M.DE drawdown since its inception was -67.19%, which is greater than DXSE.DE's maximum drawdown of -34.30%. Use the drawdown chart below to compare losses from any high point for GN0M.DE and DXSE.DE.
Loading charts...
Drawdown Indicators
| GN0M.DE | DXSE.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.19% | -34.30% | -32.89% |
Max Drawdown (1Y)Largest decline over 1 year | -16.68% | -12.67% | -4.01% |
Max Drawdown (3Y)Largest decline over 3 years | -48.19% | -28.10% | -20.09% |
Max Drawdown (5Y)Largest decline over 5 years | — | -28.10% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -28.10% | — |
Current DrawdownCurrent decline from peak | -41.03% | -13.88% | -27.15% |
Average DrawdownAverage peak-to-trough decline | -43.13% | -8.34% | -34.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.65% | 5.81% | +0.84% |
Volatility
GN0M.DE vs. DXSE.DE - Volatility Comparison
Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a higher volatility of 8.15% compared to Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) at 5.82%. This indicates that GN0M.DE's price experiences larger fluctuations and is considered to be riskier than DXSE.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GN0M.DE | DXSE.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.15% | 5.82% | +2.33% |
Volatility (6M)Calculated over the trailing 6-month period | 19.69% | 11.95% | +7.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.68% | 17.63% | +10.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.49% | 16.48% | +15.01% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.49% | 16.04% | +15.45% |
GN0M.DE vs. DXSE.DE - Expense Ratio Comparison
GN0M.DE has a 0.50% expense ratio, which is higher than DXSE.DE's 0.17% expense ratio.
Dividends
GN0M.DE vs. DXSE.DE - Dividend Comparison
Neither GN0M.DE nor DXSE.DE has paid dividends to shareholders.
Frequently Asked Questions
GN0M.DE and DXSE.DE have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, DXSE.DE is cheaper at 0.17% per year. The better choice depends on whether you care most about return, fees, risk, or income.
DXSE.DE is cheaper with a 0.17% expense ratio, compared with 0.50% for GN0M.DE.
GN0M.DE tracks Solactive Genomics, while DXSE.DE tracks MSCI Europe Health Care ESG Screened 20-35. They also come from different issuers: Global X and Xtrackers. Their fees differ too: 0.50% for GN0M.DE and 0.17% for DXSE.DE.
Find the right allocation for GN0M.DE and DXSE.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer